Literature DB >> 2409758

Calmodulin in mast cells and its role in histamine secretion.

N Chakravarty, E H Nielsen.   

Abstract

Calmodulin content and distribution in rat peritoneal mast cells was determined by radioimmunoassay. Isolated pure mast cells were disrupted by sonication and the total calmodulin content and its distribution were determined. Calmodulin bound to the membranes was released by heating with 0.1% Lubrol PX to 95 degrees C for 5 min. The total calmodulin content of mast cells was found to be 160 +/- 14 ng/10(6) cells (9.4 +/- 0.82 pmoles/10(6) cells). The highest amount (68%) was present in the supernatant representing the cytosol. The next highest amount (26%) was found in the composite fraction consisting of mitochondria, endoplasmic reticulum, Golgi vesicles and plasma membrane (100,000 g pellet). The mast cell granules contained 4% of the total calmodulin. Trifluoperazine (TFP) was used as an antagonist to explore the role of calmodulin in histamine secretion. At 10 microM concentration, TFP caused a negligible spontaneous histamine release by its membrane effect. TFP (10 microM) inhibited histamine release by all the three secretagogues used, but the degree of inhibition varied: 60% with antigen, 40% with compound 48/80 and 20% with ionophore A23187. It is suggested that the TFP effect is due to calmodulin-antagonism and interference with the activation of enzymes, essential to the secretory process.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409758     DOI: 10.1007/bf01983117

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  9 in total

1.  On the mechanism of chlorpromazine-induced histamine release from rat mast cells.

Authors:  M Frisk-Holmberg
Journal:  Acta Physiol Scand       Date:  1971-11

2.  Time course of anaphylactic histamine release and morphological changes in rat peritoneal mast cells.

Authors:  G D Bloom; N Chakravarty
Journal:  Acta Physiol Scand       Date:  1970-03

3.  On the calcium receptor activating exocytosis: inhibitory effects of calmodulin-interacting drugs on rat mast cells.

Authors:  W W Douglas; E F Nemeth
Journal:  J Physiol       Date:  1982-02       Impact factor: 5.182

4.  Regulation of myosin light chain kinase by reversible phosphorylation and calcium-calmodulin.

Authors:  R S Adelstein; M A Conti; M D Pato
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

5.  Lanthanides are transported by ionophore A23187 and mimic calcium in the histamine secretion process.

Authors:  M Amellal; Y Landry
Journal:  Br J Pharmacol       Date:  1983-10       Impact factor: 8.739

6.  Effects of calmodulin inhibitor on histamine release from rat peritoneal mast cells induced by concanavalin A and ionophore A23187.

Authors:  T Suzuki; K Ohishi; M Uchida
Journal:  Gen Pharmacol       Date:  1983

7.  Cyclic AMP levels during stimulation and inhibition of histamine release from rat mast cells by the calmodulin inhibitor trifluoperazine.

Authors:  P E Alm
Journal:  Int Arch Allergy Appl Immunol       Date:  1983

8.  Platelet calcium-dependent proteins: identification and localization of the calcium-dependent regulator, calmodulin, in platelets.

Authors:  G C White; S N Levine; A N Steiner
Journal:  Am J Hematol       Date:  1981-06       Impact factor: 10.047

9.  Trifluoperazine inhibits 45Ca2+ uptake and catecholamine secretion and synthesis in adrenal medullary cells.

Authors:  A Wada; N Yanagihara; F Izumi; S Sakurai; H Kobayashi
Journal:  J Neurochem       Date:  1983-02       Impact factor: 5.372

  9 in total
  3 in total

Review 1.  Plenary lecture. Mechanism of histamine secretion.

Authors:  N Chakravarty
Journal:  Agents Actions       Date:  1990-04

2.  Calcium uptake in mast cells, energy metabolism and histamine secretion.

Authors:  N Chakravarty
Journal:  Agents Actions       Date:  1987-04

3.  Divalent cation dependence of the inhibition by phenothiazines of mediator release from mast cells.

Authors:  P T Peachell; F L Pearce
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.